NO974941L - Ny anvendelse av (S)-adenosyl-L-metionin(SAMe) - Google Patents

Ny anvendelse av (S)-adenosyl-L-metionin(SAMe)

Info

Publication number
NO974941L
NO974941L NO974941A NO974941A NO974941L NO 974941 L NO974941 L NO 974941L NO 974941 A NO974941 A NO 974941A NO 974941 A NO974941 A NO 974941A NO 974941 L NO974941 L NO 974941L
Authority
NO
Norway
Prior art keywords
same
adenosyl
methionine
new use
injuries
Prior art date
Application number
NO974941A
Other languages
English (en)
Other versions
NO974941D0 (no
Inventor
Georg Nemeth
Carlo Di Padova
Laszlo Szabo
Gerhard Gross
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO974941L publication Critical patent/NO974941L/no
Publication of NO974941D0 publication Critical patent/NO974941D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Anvendelse av SAMe og dets fysiologisk anvendbare salter i doser på over 2000 mg per dag og pasient til parenteral behandling av skader som er utløst gjennom fokal permanent ischemi.
NO974941A 1995-04-26 1997-10-24 Ny anvendelse av (S)-adenosyl-L-metionin(SAMe) NO974941D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19515275A DE19515275A1 (de) 1995-04-26 1995-04-26 Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
PCT/EP1996/001570 WO1996033727A1 (de) 1995-04-26 1996-04-13 NEUE VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe)

Publications (2)

Publication Number Publication Date
NO974941L true NO974941L (no) 1997-10-24
NO974941D0 NO974941D0 (no) 1997-10-24

Family

ID=7760373

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974941A NO974941D0 (no) 1995-04-26 1997-10-24 Ny anvendelse av (S)-adenosyl-L-metionin(SAMe)

Country Status (15)

Country Link
EP (1) EP0822820A1 (no)
JP (1) JPH11504023A (no)
KR (1) KR19990008061A (no)
CN (1) CN1182367A (no)
AR (1) AR001687A1 (no)
AU (1) AU5646396A (no)
CA (1) CA2216854A1 (no)
CZ (1) CZ330597A3 (no)
DE (1) DE19515275A1 (no)
HR (1) HRP960196A2 (no)
IL (1) IL117844A0 (no)
MX (1) MX9707735A (no)
NO (1) NO974941D0 (no)
WO (1) WO1996033727A1 (no)
ZA (1) ZA963296B (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37913B1 (en) * 1972-08-02 1977-11-09 Bioresearch Sas Salt of s-adenosyl-l-methionine
JPS59139319A (ja) * 1983-01-31 1984-08-10 Fuji Kagaku Kogyo Kk 脳障害による身体機能障害治療剤
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体
DE4425280C2 (de) * 1994-07-16 1997-05-07 Knoll Ag Verwendung von (S)-Adenosyl-L-methionin und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die nach temporärer fokaler Ischämie ausgelöst werden

Also Published As

Publication number Publication date
AU5646396A (en) 1996-11-18
NO974941D0 (no) 1997-10-24
MX9707735A (es) 1997-12-31
EP0822820A1 (de) 1998-02-11
CA2216854A1 (en) 1996-10-13
ZA963296B (en) 1997-10-27
CN1182367A (zh) 1998-05-20
HRP960196A2 (en) 1998-02-28
IL117844A0 (en) 1996-08-04
KR19990008061A (ko) 1999-01-25
WO1996033727A1 (de) 1996-10-31
DE19515275A1 (de) 1996-10-31
AR001687A1 (es) 1997-11-26
JPH11504023A (ja) 1999-04-06
CZ330597A3 (cs) 1998-02-18

Similar Documents

Publication Publication Date Title
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
NO332893B1 (no) Anvendelse av antistoff for fremstilling av medikament til anvendelse ved CVP-kjemoterapi
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
EP0594607A4 (en) Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens.
DK0669836T3 (da) Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænset differentieringsantigen til behandling af B-cellelymfom
PT998287E (pt) Utilizacao de levobupivacaina
DE69625157D1 (de) Behandlung des typ ii-deabetes mellitus mit amylinagonisten
IT9041529A1 (it) Dispositivo per la correzione chirurgica dell'ametropia.
LV11728A (lv) Farmaceitiska kompozicija
ES2152479T3 (es) Uso de preparaciones de inmunoglobulinas para la fabricacion de un medicamento de administracion oral para el tratamiento y la profilaxis de estados de dolor cronico.
NO981204L (no) Selektive <beta>3 -adrenergiske agonister
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
IT1249047B (it) Composizione farmaceutica per il trattamento della cataratta
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
NO974941L (no) Ny anvendelse av (S)-adenosyl-L-metionin(SAMe)
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
ATE131729T1 (de) 3,5-diiod-l-thyronin zur tsh-suppression und behandlung von struma
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NO952912D0 (no) En ny osteoblastisk proliferativ faktor
UA13253A (uk) Пристрій для лікуваhhя зміhhого мезіальhого прикусу
TW324663B (en) Interferon-ω(IFN-ω) as anti-HIV (human immune deficiency virus) agent